Lisata Therapeutics's total assets for Q1 2026 were $14.06M, a decrease of -20.77% from the previous quarter. LSTA total liabilities were $3.39M for the fiscal quarter, a 7.76% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.